ADMA Biologics Inc (ADMA)
8.81
+1.88
(+27.13%)
USD |
NASDAQ |
May 10, 16:00
8.80
-0.01
(-0.11%)
After-Hours: 20:00
ADMA Biologics Cash from Financing (Quarterly): -38.99M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -38.99M |
| September 30, 2023 | 0.4154M |
| June 30, 2023 | 0.2401M |
| March 31, 2023 | -0.6505M |
| December 31, 2022 | 62.74M |
| September 30, 2022 | -0.8438M |
| June 30, 2022 | -0.319M |
| March 31, 2022 | 47.27M |
| December 31, 2021 | 53.82M |
| September 30, 2021 | 8.203M |
| June 30, 2021 | 17.18M |
| March 31, 2021 | 41.84M |
| December 31, 2020 | 32.06M |
| September 30, 2020 | 10.63M |
| June 30, 2020 | -0.0017M |
| March 31, 2020 | 101.20M |
| December 31, 2019 | -0.0077M |
| September 30, 2019 | -0.0076M |
| June 30, 2019 | 75.84M |
| March 31, 2019 | 4.177M |
| December 31, 2018 | -0.0005M |
| September 30, 2018 | -0.0129M |
| June 30, 2018 | 42.94M |
| March 31, 2018 | -0.0044M |
| December 31, 2017 | 50.37M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.663M |
| June 30, 2017 | 13.15M |
| March 31, 2017 | -1.115M |
| December 31, 2016 | -0.0039M |
| September 30, 2016 | -0.1989M |
| June 30, 2016 | 17.04M |
| March 31, 2016 | -0.0037M |
| December 31, 2015 | -0.0593M |
| September 30, 2015 | -0.1281M |
| June 30, 2015 | 0.1297M |
| March 31, 2015 | 10.46M |
| December 31, 2014 | 5.039M |
| September 30, 2014 | -0.0491M |
| June 30, 2014 | 0.0164M |
| March 31, 2014 | 4.789M |
| December 31, 2013 | 26.67M |
| September 30, 2013 | -0.0314M |
| June 30, 2013 | 0.0687M |
| March 31, 2013 | 0.9257M |
| December 31, 2012 | 3.658M |
| September 30, 2012 | -0.0388M |
| June 30, 2012 | -0.299M |
| March 31, 2012 | 16.15M |
| December 31, 2011 | 0.015M |
| September 30, 2011 | 0.0026M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-38.99M
Minimum
Dec 2023
101.20M
Maximum
Mar 2020
21.61M
Average
8.203M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 0.00 |
| ANI Pharmaceuticals Inc | -11.92M |
| Ligand Pharmaceuticals Inc | 12.18M |
| Johnson & Johnson | 546.00M |
| Puma Biotechnology Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 17.60M |
| Cash from Investing (Quarterly) | -1.407M |
| Free Cash Flow | 3.819M |
| Free Cash Flow Per Share (Quarterly) | 0.0716 |
| Free Cash Flow to Equity (Quarterly) | 27.62M |
| Free Cash Flow Yield | 0.19% |